<DOC>
	<DOCNO>NCT00002611</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high energy x-rays damage tumor cell . It yet know whether combination chemotherapy alone combination chemotherapy plus radiation therapy effective childhood kidney cancer . PURPOSE : Phase III trial compare effectiveness combination chemotherapy without radiation therapy treat child kidney cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Alone With Radiation Therapy Treating Children With Kidney Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Increase survival rate child favorable histology ( FH ) Wilms ' tumor childhood renal tumor . - Determine whether loss heterozygosity chromosome 16q 1p tumor tissue associate poor prognosis child FH Wilms ' tumor . - Determine whether increase DNA content tumor cell associate poor prognosis child FH Wilms ' tumor . - Decrease acute long-term morbidity child Wilms ' tumor limit initial therapy consistently use regimen ( protocol NWTS-5/R ) patient relapse follow initial treatment . - Improve overall disease-free survival patient renal tumor unfavorable histology , include Wilms ' tumor diffuse anaplasia clear cell sarcoma kidney , use new treatment regimen include etoposide ( VP-16 ) cyclophosphamide ( CTX ) . - Improve overall disease-free survival patient malignant rhabdoid tumor kidney use new treatment regimen include carboplatin , VP-16 , CTX . ( The rhabdoid tumor stratum close accrual effective 07/13/2001 ) - Provide data regard loss heterozygosity chromosomes 11p15 , 16q , 1p , age diagnosis , precursor lesion ( perilobar , intralobar , nephroblastomatosis ) , bilaterality , presence congenital anomaly require completion protocol A0026 ( case-control study risk factor Wilms ' tumor ) . OUTLINE : This multicenter study . Patients assign one nine stratum base tumor histology , stage , tumor weight , age . - Stratum 1 ( stage I favorable histology ( FH ) Wilms ' tumor , 24 month age , tumor weight less 550 g ) : After nephrectomy , patient receive regimen EE-4A comprise dactinomycin ( DACT ) IV weekly week 0 , 3 , 6 , 9 , 12 , 15 , 18 vincristine ( VCR ) IV weekly week 1-10 , 12 , 15 , 18 . - Stratum 2 ( stage I FH Wilms ' tumor age 24 month tumor weight least 550 g ; stage I focal anaplastic ( FA ) diffuse anaplastic ( DA ) Wilms ' tumor ) : Patients receive therapy stratum 1 . - Stratum 3 ( stage II FH Wilms ' tumor ) : Patients receive therapy stratum 1 . - Stratum 4 ( stage III FH Wilms ' tumor ; stage II III FA Wilms ' tumor ) : After nephrectomy , patient receive regimen DD-4A comprise DACT IV weekly week 0 , 6 , 12 , 18 , 24 ; doxorubicin IV weekly week 3 , 9 , 15 , 21 ; VCR IV weekly week 1-10 , 12 , 15 , 18 , 21 , 24 . Patients also undergo abdominal radiotherapy . - Stratum 5 ( stage IV FH FA Wilms ' tumor ) : Patients receive chemotherapy stratum 4 , abdominal radiotherapy , whole lung radiotherapy ( discretion investigator ) . - Stratum 6 ( stage V FH , FA , DA Wilms ' tumor ) : After bilateral biopsy , patient FH receive chemotherapy stratum 1 4 . Patients FA DA receive chemotherapy stratum 7 . - Stratum 7 ( stage I-IV clear cell sarcoma ) : After nephrectomy , patient receive VCR IV weekly week 1 , 2 , 4-8 , 10-13 , 18 , 24 ; cyclophosphamide ( CTX ) IV 1 hour day 1-3 week 6 , 12 , 18 , 24 day 1-5 week 3 , 9 , 15 , 21 ; doxorubicin IV ( begin CTX infusion ) weekly week 0 , 6 , 12 , 18 , 24 ; etoposide ( VP-16 ) IV 1 hour ( begin CTX infusion ) day 1-5 week 3 , 9 , 15 , 21 . Filgrastim ( G-CSF ) administer subcutaneously ( SC ) begin 24 hour completion chemotherapy continue blood count recover . Patients also undergo abdominal radiotherapy whole lung radiotherapy ( pulmonary metastasis present ) . - Stratum 8 ( stage II-IV DA Wilms ' tumor ) : Patients receive treatment stratum 7 . - Stratum 9 ( stage I-IV rhabdoid tumor ) : After nephrectomy , patient receive carboplatin IV day 1-2 VP-16 IV 1 hour ( begin carboplatin infusion ) day 1-3 week 0 , 3 , 9 , 12 , 18 , 21 CTX IV 1 hour day 1-5 week 6 , 15 , 24 . G-CSF administer stratum 7 . Patients also undergo radiotherapy . ( The rhabdoid tumor stratum close accrual effective 07/13/2001 . ) After completion chemotherapy , patient undergo second-look laparotomy partial nephrectomy wedge excision ( feasible ) . After second-look surgery , patient without persistent residual disease resume chemotherapy . Patients follow every 3 month 5 year , every 6 month 2 year , annually 3 year . PROJECTED ACCRUAL : A total 207 patient accrue treatment portion study . ( The rhabdoid tumor stratum close accrual effective 07/13/2001 . )</detailed_description>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<mesh_term>Dactinomycin</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage IV kidney cancer one follow histology : Wilms ' tumor , favorable histology Wilms ' tumor , focal diffuse anaplastic Clear cell sarcoma Rhabdoid tumor ( The rhabdoid tumor stratum close accrual effective 07/13/2001 ) Prior nephrectomy biopsy require Prior bilateral biopsy ( preferably open ) bilateral stag pathologic evaluation require bilateral tumor Must begin study therapy within 5 day nephrectomy ( unless medically contraindicate ) PATIENT CHARACTERISTICS : Age : Under 16 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>stage I Wilms tumor</keyword>
	<keyword>stage II Wilms tumor</keyword>
	<keyword>stage III Wilms tumor</keyword>
	<keyword>stage IV Wilms tumor</keyword>
	<keyword>stage V Wilms tumor</keyword>
	<keyword>clear cell sarcoma kidney</keyword>
</DOC>